Abstract:Background: Recent studies have reported the tumor suppressive role of miR-5195-3p in the progression of several cancers, but the potential roles of miR-5195-3p in ovarian cancer (OC) remain largely unknown. Methods: We first analyzed the expression levels of miR-5195-3p in 83 pairs of human OC tissues and adjacent specimens by reverse transcription-quantitative PCR. The correlation of miR-5195-3p/rhomboid domain containing 1 (RHBDD1) and clinicopathological parameters was analyzed by chi-square test. The prognostic value of miR-5195-3p was evaluated by Kaplan-Meier method Cox proportional hazards models. The effects of miR-5195-3p on cell proliferation, cell cycle distribution, migration and invasion were examined by CCK-8 assay, colony formation assay, flow cytometry and transwell assay. Tumor forming was evaluated by nude mice model in vivo. The association between miR-5195-3p and RHBDD1 was verified by luciferase reporter assay. Results: We observed that miR-5195-3p level was remarkably reduced in OC tissues as compared to adjacent tissues. The expression of miR-5195-3p was associated with FIGO stage, depth of invasion and poor survival prognosis in OC patients. Overexpression of miR-5195-3p significantly suppressed cell proliferation, cell cycle G1/S transition, migration and invasion in OC cell lines (SKOV-3 and OVCAR3), while knockdown of miR-5195-3p obtained the opposite results. We further confirmed miR-5195-3p as a negative post-transcriptional modulator of RHBDD1. RHBDD1 expression was upregulated in OC tissues compared with adjacent tissues, which was inversely correlated with miR-5195-3p expression. The expression of RHBDD1 was associated with FIGO stage and distant metastasis. RHBDD1 overexpression reversed the suppressive role of miR-5195-3p on OC cell proliferation, migration and invasion. Consistent with the in vitro results, miR-5195-3p overexpression decreased the growth of subcutaneously inoculated tumors in nude mice. Conclusions: Taken together, the present results indicated that miR-5195-3p acts a tumor suppressor by targeting RHBDD1 in OC.

Knockdown of mediator complex subunit 19 inhibits the growth of ovarian cancer.

Knockdown Of Med19 By Lentivirus-Mediated Shrna In Human Osteosarcoma Cells Inhibits Cell Proliferation By Inducing Cell Cycle Arrest In The G(0)/G(1) Phase

Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor.

MED19 Promotes Proliferation and Tumorigenesis of Lung Cancer

Expression of Med19 in bladder cancer tissues and its role on bladder cancer cell growth.

Knockdown of Med19 suppresses proliferation and enhances chemo-sensitivity to cisplatin in non-small cell lung cancer cells.

Downregulation of Hsa_circ_0026123 Suppresses Ovarian Cancer Cell Metastasis and Proliferation Through the Mir‑124‑3p/ezh2 Signaling Pathway.

The Role of Med19 in the Proliferation and Tumorigenesis of Human Hepatocellular Carcinoma Cells.

MiR-5195-3p functions as a tumor suppressor by targeting RHBDD1 in ovarian cancer

Research on Function of Med19 Gene Expression in Saos2 Cell's Proliferation

Role of Med19 in the Proliferation and Tumorigenicity of Human Bladder Cancer Cells

Mediator of RNA Polymerase II Transcription Subunit 19 Promotes Osteosarcoma Growth and Metastasis and Associates with Prognosis

Anti-miR182 Reduces Ovarian Cancer Burden, Invasion, and Metastasis: an in Vivo Study in Orthotopic Xenografts of Nude Mice.

Downregulation of DNMT3A Attenuates the Warburg Effect, Proliferation, and Invasion via Promoting the Inhibition of miR-603 on HK2 in Ovarian Cancer

Mediator Complex Subunit 19 Promotes the Development of Hepatocellular Carcinoma by Regulating the AKT/mTOR Signaling Pathway

Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells

Mir-638 Suppresses Proliferation by Negatively Regulating High Mobility Group A1 in Ovarian Cancer Cells.

Knockdown of TMEM45A gene suppresses proliferation, induces cell cycle arrest and reduces invasion ability of human ovarian cancer cells

Inhibitory Effect of STAT3 Silenced with RNAi on Growth of Human Ovarian Cancer SKOV3 Cell Transplanted Tumor in Nude Mice

Knockdown of TRIM44 inhibits the progression of ovarian cancer and is related to the FOXM1-EZH2 signaling pathway

MicroRNA-592 Inhibits the Growth of Ovarian Cancer Cells by Targeting ERBB3